Novadiscovery raises series A financing to scale its in silico clinical trial platform
in silico trials have become a concrete and important option to predict drug efficacy and optimize time and costs of clinical development.
How will in silico medicine change the future of clinical trials?
The Avicenna Alliance member Dassault 3DS and Dr. Tina Morrison from the FDA contributed to an interesting article on the latest simulation model of the heart developed as part of the Living Heart Project.
Common European data spaces
On 17 December 2020, DG CONNECT published the reports and conclusions of 10 workshops on ‘common European data spaces’ that took place from July to November 2019 in the EU.